Noa G. Holtzman

Noa G. Holtzman

Transplant Surgery | Hematology Oncology

1475 Northwest 12th Avenue
Miami, FL 33136

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Transfusion Support After CAR-T Cell Therapy: Real-World Patterns Across Commercial Products and Disease Groups.

Transfusion Support After CAR-T Cell Therapy: Real-World Patterns Across Commercial Products and Disease Groups.

Journal: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Published: June 01, 2026

Refractory and/or Resistant Herpes Simplex Virus Mucocutaneous Infections in Adult Transplantation and Cellular Therapy Patients: A Single-Center Experience.

Refractory and/or Resistant Herpes Simplex Virus Mucocutaneous Infections in Adult Transplantation and Cellular Therapy Patients: A Single-Center Experience.

Journal: Cureus

Published: May 31, 2026

Viral Culture Conversion with use of Remdesivir for Respiratory Syncytial Virus Lower Respiratory Tract Infection.

Viral Culture Conversion with use of Remdesivir for Respiratory Syncytial Virus Lower Respiratory Tract Infection.

Journal: The Journal of infectious diseases

Published: May 28, 2026

False-positive HIV-1 RNA detection following obecabtagene autoleucel.

False-positive HIV-1 RNA detection following obecabtagene autoleucel.

Journal: Bone marrow transplantation

Published: April 15, 2026

Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Journal: American journal of hematology

Published: March 09, 2026

Desmosine as a Novel Biomarker Candidate for Pulmonary and Cutaneous Chronic Graft-versus-Host Disease.

Desmosine as a Novel Biomarker Candidate for Pulmonary and Cutaneous Chronic Graft-versus-Host Disease.

Journal: Transplantation and cellular therapy

Published: February 23, 2026

Desmosine as a Novel Biomarker Candidate for Pulmonary and Cutaneous Chronic Graft-Versus-Host Disease.

Desmosine as a Novel Biomarker Candidate for Pulmonary and Cutaneous Chronic Graft-Versus-Host Disease.

Journal: Transplantation and cellular therapy

Published: February 23, 2026

Toward Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task Force.

Toward Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task Force.

Journal: Transplantation and cellular therapy

Published: November 14, 2025

Baricitinib for refractory chronic graft-versus-host disease: results of a phase 1/2 study.

Baricitinib for refractory chronic graft-versus-host disease: results of a phase 1/2 study.

Journal: Blood advances

Published: October 27, 2025

Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 study.

Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 study.

Journal: Blood advances

Published: October 27, 2025

Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary Era.

Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary Era.

Journal: Mycopathologia

Published: October 27, 2025

Cytomegalovirus Lymphadenitis Mimicking Relapsed Lymphoma After CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy.

Cytomegalovirus Lymphadenitis Mimicking Relapsed Lymphoma After CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: July 18, 2025

Showing 1-12 of 64

Last Updated: 09/26/2026